This report focuses on the global Deuterated Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Deuterated Drugs development in North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, etc.
Segment by Type
Austedo
Zepsun
Others
Segment by Application
Huntington'S Disease (HD)
Tardive Dyskinesia (TD)
Cancer
Others
By Region
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
By Company
Teva
Suzhou Zelgen Biopharmaceuticals
Concert Pharmaceuticals
Vertex Pharmaceuticals
Hinova Pharma
Otsuka Pharmaceutical (Avanir)
Poxel SA (DeuteRx)
